BIIB
Biogen Inc
Price:  
155.33 
USD
Volume:  
1,048,200.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen WACC - Weighted Average Cost of Capital

The WACC of Biogen Inc (BIIB) is 8.0%.

The Cost of Equity of Biogen Inc (BIIB) is 9.40%.
The Cost of Debt of Biogen Inc (BIIB) is 4.30%.

Range Selected
Cost of equity 7.90% - 10.90% 9.40%
Tax rate 13.90% - 16.80% 15.35%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.8% - 9.2% 8.0%
WACC

Biogen WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.90%
Tax rate 13.90% 16.80%
Debt/Equity ratio 0.3 0.3
Cost of debt 4.00% 4.60%
After-tax WACC 6.8% 9.2%
Selected WACC 8.0%